Black Diamond Therapeutics
BDTX
BDTX
88 hedge funds and large institutions have $717M invested in Black Diamond Therapeutics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less capital invested
Capital invested by funds: $968M → $717M (-$251M)
Holders
88
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$23.8M | |
| 2 | +$10.4M | |
| 3 | +$8.06M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$5.79M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.48M |
Top Sellers
| 1 | -$44M | |
| 2 | -$16M | |
| 3 | -$6.48M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.51M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$3.46M |